IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Recent Updates — RMTI

August 13, 2026View Source ↗

Rockwell Medical reported second quarter 2026 net sales of $17.8 million, an 11% increase year-over-year, with gross margin expanding to 18%. The company generated $2.1 million in operating cash flow and ended the quarter with $24.8 million in cash. This filing announces a 1-for-10 reverse stock split that became effective on July 1, 2026, allowing the company to regain compliance with Nasdaq's minimum bid price requirement. Rockwell Medical operates in the healthcare industry, developing and distributing hemodialysis products.

July 20, 2026View Source ↗

Rockwell Medical, Inc. received written notification from Nasdaq on July 16, 2026, confirming the company has regained compliance with the minimum $1.00 per share bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company maintained a minimum closing bid price of $1.00 or greater between July 1, 2026, and July 15, 2026, resulting Nasdaq to consider the compliance matter closed. Rockwell Medical is now in full compliance with all Nasdaq continued listing requirements. Rockwell Medical is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products.

June 29, 2026View Source ↗

Rockwell Medical, Inc. filed a certificate of amendment to its certificate of incorporation to implement a one-for-ten reverse stock split of its common stock. The split is scheduled to effective at 12:01 a.m. Eastern Time on July 1, 2026, and will result in stockholders with fractional shares to receive cash in lieu of fractional shares. Rockwell Medical, Inc. operates in the healthcare industry and provides medical technology solutions.

June 15, 2026View Source ↗

Rockwell Medical, Inc. held its 2026 Annual Meeting of Stockholders on June 12, 2026. Shareholders approved the election of Class II directors Joseph Dawson and Joan Lau, Ph.D., and ratified EisnerAmper LLP as the independent auditor for 2026. However, stockholders rejected the advisory vote on executive compensation and failed to approve an amendment to the Certificate of Incorporation to effect a reverse stock split. Rockwell Medical, Inc. is a medical technology company.